<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03143205</url>
  </required_header>
  <id_info>
    <org_study_id>K23DA039800</org_study_id>
    <nct_id>NCT03143205</nct_id>
  </id_info>
  <brief_title>Gene Expression Outcomes in Interventions for Substance Using HIV+ Minority Men</brief_title>
  <official_title>Gene Expression Outcomes in Interventions for Substance Using HIV+ Minority Men</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pilot study of a new 9-session individually delivered cognitive behavioral
      intervention targeting sexual minority stress. In this study, 40 HIV+ men sexual minority men
      will be recruited for the study then will be randomly assigned to either the new 9 session
      intervention or a writing task condition.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 5, 2017</start_date>
  <completion_date type="Anticipated">October 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Gene expression</measure>
    <time_frame>Baseline, ~9 weeks (at conclusion of intervention), 4 month follow-up</time_frame>
    <description>Gene expression related to inflammation measured in blood</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Substance Use</measure>
    <time_frame>Baseline, ~9 weeks (at conclusion of intervention), 4 month follow-up</time_frame>
    <description>Substance Use measured through Alcohol Smoking and Substance Involvement Screening Test (ASSIST)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Human Immunodeficiency Virus Infection</condition>
  <condition>Inflammation</condition>
  <arm_group>
    <arm_group_label>AWARENESS for sexual minorities</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group receives new CBT-based intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Writing tasks</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group receives writing-based sessions</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>AWARENESS for Sexual Minorities</intervention_name>
    <description>9 session, individually delivered, cognitive behavioral intervention focused on modifying sexual minority stress responses to reduce the impact of sexual minority stress experiences.</description>
    <arm_group_label>AWARENESS for sexual minorities</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Writing tasks</intervention_name>
    <description>Writing sessions to explore daily activities.</description>
    <arm_group_label>Writing tasks</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Provide evidence or documentation of HIV positive status (e.g. a letter of diagnosis
             or medication bottles with matched photo ID)

          -  Be English speaking

          -  Be able to consent

          -  Sexual activity with a man in the 3 years prior to initial contact or identification
             as gay or bisexual

          -  Not currently be enrolled in formal substance abuse treatment

          -  Report at least one occasion of drinking 5 or more drinks or of using an illicit
             substance in the previous 3 months, but not meet criteria for a severe substance use
             disorder.

        Exclusion Criteria:

          -  Presence of a severe substance use disorder

          -  Presence of current symptoms consistent with schizophrenia or bipolar disorder, which
             would indicate that an intervention targeting these symptoms would be more
             appropriate.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Participant must self-identify as male at the time of screening into the study</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Annesa C Flentje, PhD</last_name>
    <phone>4155020697</phone>
    <email>annesa.flentje@ucsf.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of California, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annesa Flentje, PhD</last_name>
      <phone>415-502-0697</phone>
      <email>annesa.flentje@ucsf.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 2, 2017</study_first_submitted>
  <study_first_submitted_qc>May 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 8, 2017</study_first_posted>
  <last_update_submitted>May 12, 2017</last_update_submitted>
  <last_update_submitted_qc>May 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Francisco</investigator_affiliation>
    <investigator_full_name>Annesa Flentje</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Immunologic Deficiency Syndromes</mesh_term>
    <mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
    <mesh_term>HIV Infections</mesh_term>
    <mesh_term>Virus Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

